BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6253063)

  • 21. Ecto-5'nucleotidase activity in B and T lymphocytes and monocytes of patients with multiple sclerosis.
    Armstrong MA; Haire M
    Ann Neurol; 1986 Jan; 19(1):94-6. PubMed ID: 3004321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of lymphocyte ecto-5'-nucleotidase in infants with reticuloendotheliosis and eosinophilia (Omenn's syndrome).
    Gelfand EW; McCurdy D; Rao CP; Cohen A
    Blood; 1984 Jun; 63(6):1475-80. PubMed ID: 6326896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential importance of soluble deoxynucleotidase activity in mediating deoxyadenosine toxicity in human lymphoblasts.
    Carson DA; Kaye J; Wasson DB
    J Immunol; 1981 Jan; 126(1):348-52. PubMed ID: 6256438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
    Leyva A; Appel H; Pinedo HM
    Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of 9-beta-D-arabinofuranosyladenine-resistant human T-lymphoblasts with altered ribonucleotide reductase activity.
    Fridland A
    Cancer Res; 1984 Oct; 44(10):4328-32. PubMed ID: 6380707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymes of purine metabolism in human peripheral lymphocyte subpopulations.
    Massaia M; Ma DD; Sylwestrowicz TA; Tidman N; Price G; Janossy G; Hoffbrand AV
    Clin Exp Immunol; 1982 Oct; 50(1):148-54. PubMed ID: 6293742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential metabolism of deoxyribonucleosides by leukaemic T cells of immature and mature phenotype.
    Sidi Y; Edwards NL; Winkler C; Bunn P; Mitchell BS
    Br J Haematol; 1985 Sep; 61(1):125-34. PubMed ID: 2996581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha-L-Fucosidase activity and isoenzyme characteristics analyzed by chromatofocusing in normal and leukemic lymphocytes.
    Orlacchio A; Maffei C; Rambotti P; Davis S
    Anticancer Res; 1984; 4(6):431-4. PubMed ID: 6335016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity of human leukemic T cell lines and B cell lines to growth inhibition by deoxyadenosine.
    Carson DA; Kaye J; Seegmiller JE
    J Immunol; 1978 Nov; 121(5):1726-31. PubMed ID: 309480
    [No Abstract]   [Full Text] [Related]  

  • 31. Cross-killing phenomenon during induction of cytotoxic activity against autologous leukemic cells or autologous Epstein-Barr virus-transformed lymphoblastoid B-cell line.
    Maeda Y; Hijikata Y; Yamaguchi T; Morita Y; Kanamaru A
    Leuk Res; 2008 Mar; 32(3):510-1. PubMed ID: 17628665
    [No Abstract]   [Full Text] [Related]  

  • 32. The expression of deoxyguanosine toxicity in T lymphocytes at different stages of maturation.
    Cohen A; Lee JW; Dosch HM; Gelfand EW
    J Immunol; 1980 Oct; 125(4):1578-82. PubMed ID: 6967909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical basis for differential deoxyadenosine toxicity to T and B lymphoblasts: role for 5'-nucleotidase.
    Wortmann RL; Mitchell BS; Edwards NL; Fox IH
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2434-7. PubMed ID: 221924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
    Poplack DG; Blatt J; Reaman G
    Cancer Res; 1981 Nov; 41(11 Pt 2):4821-23. PubMed ID: 6271395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy.
    Mountford CE; Grossman G; Reid G; Fox RM
    Cancer Res; 1982 Jun; 42(6):2270-6. PubMed ID: 6280854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease in 5'-nucleotidase activity in malignant transformed and normal stimulated cells.
    Raz A; Collard JG; Inbar M
    Cancer Res; 1978 May; 38(5):1258-62. PubMed ID: 639059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes.
    Liebes LF; Krigel RL; Conklyn M; Nevrla DR; Silber R
    Cancer Res; 1983 Nov; 43(11):5608-17. PubMed ID: 6604577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxyribonucleoside triphosphate pools in human diploid fibroblasts and their modulation by hydroxyurea and deoxynucleosides.
    Snyder RD
    Biochem Pharmacol; 1984 May; 33(9):1515-8. PubMed ID: 6732868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of 5'-nucleotidase in human lymphoid tissues.
    Edwards NL; Gelfand EW; Burk L; Dosch HM; Fox IH
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3474-6. PubMed ID: 315065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and properties of a monoclonal antibody specific for human ecto-5'-nucleotidase.
    Kummer U; Mysliwietz J; Gutensohn W; Buschette S; Jahn H; Neuser D; Munker R
    Immunobiology; 1984 Mar; 166(2):203-11. PubMed ID: 6327507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.